Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
Dulaglutide, a weekly injectable glucagon-like peptide-1 receptor agonist, has demonstrated effectiveness when combined with basal insulin. We examined whether the efficacy of dulaglutide is comparable to that of prandial insulin in kidney transplant (KT) recipients with type 2 diabetes mellitus (T2...
Guardado en:
Autores principales: | Hwi Seung Kim, Jiwoo Lee, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0a3db234543460e922178aa4c46167d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
por: Kutoh Eiji, et al.
Publicado: (2019) -
Temporal characterization of the insulin resistance during puberty in mice
por: Teixeira Pryscila D.S., et al.
Publicado: (2021) -
Rapid Desensitization for Insulin Allergy in Type 1 Diabetes Using an Insulin Pump: A Case Report and Literature Review
por: Kristy Tian, MBBS, MRCP, MMed, et al.
Publicado: (2021) -
Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness
por: Eli Ipp
Publicado: (2021) -
LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity
por: Radikova Zofia, et al.
Publicado: (2018)